HMG20B antibody
Quick Overview for HMG20B antibody (ABIN2855769)
Target
See all HMG20B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human
-
Characteristics
-
Rabbit Polyclonal antibody to BRAF35 (high-mobility group 20B)
BRAF35 antibody -
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the center region of human BRAF35. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IP: 1:100-1:500. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: 293T
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.95 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 10 % Glycerol, 0.01 % Thimerosal
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- HMG20B (High Mobility Group 20B (HMG20B))
-
Alternative Name
- high mobility group 20B
-
Background
-
Required for correct progression through G2 phase of the cell cycle and entry into mitosis. Required for RCOR1/CoREST mediated repression of neuronal specific gene promoters.
Cellular Localization: Nucleus -
Molecular Weight
- 36 kDa
-
Gene ID
- 10362
-
UniProt
- Q9P0W2
Target
-